STRATEC Biomedical Systems AG / Dividend 18.03.2008 Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- STRATEC Board of Management plans to increase dividend by 47% Birkenfeld, March 18, 2008 The Board of Management of STRATEC Biomedical Systems AG has compiled the annual financial statements for the 2007 financial year. In view of the very strong earnings performance of the STRATEC Group in 2007 and in the expectation that the business will continue to perform positively, the Board of Management will propose in the profit appropriation proposal which it submits to the Supervisory Board that the dividend for the 2007 financial year be increased by 47% to Euro 0.22 per share (previous year: Euro 0.15). --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: About STRATEC STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and on other exchanges. The STRATEC Group consists of the publicly listed parent company STRATEC Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Rumania. Further information can be obtained from: STRATEC Biomedical Systems AG André Loy, Investor Relations Gewerbestr. 37, 75217 Birkenfeld Germany Tel: +49 7082 7916-190 Fax: +49 7082 7916-999 E-mail: ir@stratec-biomedical.de DGAP 18.03.2008 --------------------------------------------------------------------------- Language: English Issuer: STRATEC Biomedical Systems AG Gewerbestraße 37 75217 Birkenfeld Deutschland Phone: +49 (0)7082 7916 0 Fax: +49 (0)7082 7916 999 E-mail: info@stratec-biomedical.de Internet: www.stratec-biomedical.de ISIN: DE0007289001 WKN: 728900 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Stuttgart, München, Düsseldorf End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: STRATEC Board of Management plans to increase dividend by 47%
| Source: EQS Group AG